{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:00:36Z","timestamp":1792634436804,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007475","name":"Canadian Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007475","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jaad.2024.01.078","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T20:44:55Z","timestamp":1708461895000},"page":"43-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Negative impact of comorbidities on all-cause mortality of patients with psoriasis is partially alleviated by biologic treatment: A real-world case-control study"],"prefix":"10.1016","volume":"91","author":[{"given":"Saba","family":"Riaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Emam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gniadecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2024.01.078_bib1","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s13555-021-00518-8","article-title":"Psoriasis prevalence and\u00a0severity by expert elicitation","volume":"11","author":"Papp","year":"2021","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.jaad.2024.01.078_bib2","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaad.2018.12.037","article-title":"All-cause and cause-specific mortality in psoriasis: a systematic review and meta-analysis","volume":"80","author":"Dhana","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2024.01.078_bib3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","article-title":"The risk of mortality in patients with psoriasis: results from a population-based study","volume":"143","author":"Gelfand","year":"2007","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.01.078_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/B:EJEP.0000020447.59150.f9","article-title":"Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients","volume":"19","author":"Mallbris","year":"2003","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"10.1016\/j.jaad.2024.01.078_bib5","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s13555-021-00590-0","article-title":"Psoriasis and cardiometabolic comorbidities: an evaluation of the impact of systemic treatments in randomized clinical trials","volume":"11","author":"Mosca","year":"2021","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jaad.2024.01.078_bib6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bjd.15021","article-title":"Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study","volume":"176","author":"Springate","year":"2017","journal-title":"Br J Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2024.01.078_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","article-title":"The concept of psoriasis as a systemic inflammation: implications for disease management","volume":"26","author":"Reich","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2024.01.078_bib8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jaad.2019.08.011","article-title":"Psoriasis and mortality in the United States: data from the National Health and Nutrition Examination Survey","volume":"85","author":"Semenov","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.01.078_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10238-022-00820-5","article-title":"The association between platelet\u00a0indices and presence and severity of psoriasis: a systematic review and meta-analysis","volume":"23","author":"Liu","year":"2023","journal-title":"Clin Exp Med"},{"issue":"5","key":"10.1016\/j.jaad.2024.01.078_bib10","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaad.2020.10.031","article-title":"Trends in mortality and cause-specific mortality among patients with psoriasis and psoriatic arthritis in Ontario, Canada","volume":"84","author":"Colaco","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.01.078_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","article-title":"Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.01.078_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaad.2018.06.056","article-title":"Psoriasis: which therapy for which patient: focus on special populations and chronic infections","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.01.078_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2796.2012.02593.x","article-title":"Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study","volume":"273","author":"Ahlehoff","year":"2013","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.jaad.2024.01.078_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12016-016-8560-9","article-title":"The effect of TNF inhibitors on cardiovascular events in psoriasis and psoriatic arthritis: an updated meta-analysis","volume":"51","author":"Yang","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2024.01.078_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2020.08.032","article-title":"Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): a nested case-control analysis","volume":"84","author":"Langley","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.01.078_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/CCM.0000000000005275","article-title":"Association between pandemic coronavirus disease 2019 public health measures and reduction in critical care utilization across ICUs in Alberta, Canada","volume":"50","author":"Bagshaw","year":"2022","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.jaad.2024.01.078_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.cjco.2021.12.007","article-title":"Effect of new evidence on antithrombotic therapies in atrial fibrillation patients who undergo percutaneous coronary intervention in Alberta, Canada","volume":"4","author":"Eberhardt","year":"2022","journal-title":"CJC Open"},{"issue":"11","key":"10.1016\/j.jaad.2024.01.078_bib18","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.jaad.2024.01.078_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1631\/jzus.B1300109","article-title":"Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy","volume":"15","author":"Huang","year":"2014","journal-title":"J Zhejiang Univ Sci B"},{"issue":"5","key":"10.1016\/j.jaad.2024.01.078_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jaad.2024.01.078_bib21","series-title":"Basic Statistical Analysis","first-page":"99","author":"Sprinthall","year":"2012"},{"issue":"4","key":"10.1016\/j.jaad.2024.01.078_bib22","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1213\/ANE.0000000000005358","article-title":"Kaplan-meier curves, log-rank tests, and cox regression for time-to-event data","volume":"132","author":"Schober","year":"2021","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.jaad.2024.01.078_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/EDE.0000000000000283","article-title":"Estimating excess hazard ratios and net survival when covariate data are missing: strategies for multiple imputation","volume":"26","author":"Falcaro","year":"2015","journal-title":"Epidemiology"},{"issue":"2","key":"10.1016\/j.jaad.2024.01.078_bib24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ije\/dyp392","article-title":"Measuring cancer survival in populations: relative survival vs cancer-specific survival","volume":"39","author":"Sarfati","year":"2010","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.jaad.2024.01.078_bib25","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/ijc.21909","article-title":"Trends in survival and excess risk of death after diagnosis of cancer in 1980-1996 in New South Wales, Australia","volume":"119","author":"Yu","year":"2006","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.jaad.2024.01.078_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12891-021-04379-2","article-title":"Testing the proportional hazards assumption in cox regression and dealing with possible non-proportionality in total joint arthroplasty research: methodological perspectives and review","volume":"22","author":"Kuitunen","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jaad.2024.01.078_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.conctc.2017.09.004","article-title":"Estimation of treatment effects in weighted log-rank tests","volume":"8","author":"Lin","year":"2017","journal-title":"Contemp Clin Trials Commun"},{"issue":"5","key":"10.1016\/j.jaad.2024.01.078_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3348\/kjr.2022.0061","article-title":"Restricted mean survival time for survival analysis: a quick guide for clinical researchers","volume":"23","author":"Han","year":"2022","journal-title":"Korean J Radiol"},{"issue":"3","key":"10.1016\/j.jaad.2024.01.078_bib29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s13193-012-0149-z","article-title":"Statistics for surgeons - understanding survival analysis","volume":"3","author":"Agarwal","year":"2012","journal-title":"Indian J Surg Oncol"},{"issue":"7","key":"10.1016\/j.jaad.2024.01.078_bib30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jclinepi.2009.12.008","article-title":"Missing covariate data in medical research: to impute is better than to ignore","volume":"63","author":"Janssen","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jaad.2024.01.078_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2310\/7750.2010.10013","article-title":"Long-term prognosis and comorbidities associated with psoriasis in the Newfoundland and Labrador founder population","volume":"15","author":"Gulliver","year":"2011","journal-title":"J Cutan Med Surg"},{"issue":"7","key":"10.1016\/j.jaad.2024.01.078_bib32","first-page":"809","article-title":"Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register study","volume":"95","author":"Svedbom","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2024.01.078_bib33","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1038\/s41598-020-61872-9","article-title":"Presentations, causes and outcomes of drug-induced liver injury in Egypt","volume":"10","author":"Alhaddad","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jaad.2024.01.078_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1517\/14740338.2.3.249","article-title":"Antidepressant-induced hepatotoxicity","volume":"2","author":"Lucena","year":"2003","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"10.1016\/j.jaad.2024.01.078_bib35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.5604\/01.3001.0009.8600","article-title":"Drug induced liver injury at a tertiary hospital in India: etiology, clinical features and predictors of mortality","volume":"16","author":"Rathi","year":"2017","journal-title":"Ann Hepatol"},{"issue":"11","key":"10.1016\/j.jaad.2024.01.078_bib36","first-page":"1169","article-title":"Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method","volume":"14","author":"Teschke","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jaad.2024.01.078_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101811","article-title":"Prevalence and health outcomes of polypharmacy and hyperpolypharmacy in older adults with frailty: a systematic review and meta-analysis","volume":"83","author":"Toh","year":"2023","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jaad.2024.01.078_bib38","series-title":"StatPearls","article-title":"Polypharmacy","author":"Varghese","year":"2022"},{"issue":"10211","key":"10.1016\/j.jaad.2024.01.078_bib39","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(19)32316-5","article-title":"A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study","volume":"394","author":"Plana-Ripoll","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2024.01.078_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2022.104630","article-title":"Association between polypharmacy and mortality in the older adults: a systematic review and meta-analysis","volume":"100","author":"Li","year":"2022","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"10.1016\/j.jaad.2024.01.078_bib41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/neurolint14010024","article-title":"Antipsychotic polypharmacy-related cardiovascular morbidity and mortality: a comprehensive review","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurol Int"},{"issue":"6","key":"10.1016\/j.jaad.2024.01.078_bib42","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jaad.2021.02.019","article-title":"Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: a population-based study","volume":"84","author":"Gelfand","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"14","key":"10.1016\/j.jaad.2024.01.078_bib43","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224003827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224003827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T06:37:10Z","timestamp":1722321430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224003827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0190962224003827"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.01.078","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Negative impact of comorbidities on all-cause mortality of patients with psoriasis is partially alleviated by biologic treatment: A real-world case-control study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.01.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}